Skip to main content

Year: 2026

FY26 Update, Business Reorganisation and FY27 Outlook

PayPoint Plc 30 March 2026FY26 Update, Business Reorganisation and FY27 Outlook FY26 Update PayPoint Plc (“PayPoint” or the “Group”) today issues an unaudited trading update for the financial year ended 31 March 2026. The Group anticipates it will deliver a record financial performance for FY26, broadly in line with expectations. Consistent with the extended and increased buyback programme announced on 1 July 2025, as of market close on 25 March 2026, a total of 3,957,613 shares have been purchased at a total value of £23.8 million. The Group remains on course to reduce its issued share capital by circa 30% in the three years to FY28 while continuing to grow the ordinary dividend, with share capital already reduced by circa15% in the current year. Business Reorganisation The Board also today announces that it has taken the decision to...

Continue reading

Eurocastle Releases Fourth Quarter and Year End 2025 Financial Results

EUROCASTLE INVESTMENT LIMITED                                       FOR IMMEDIATE RELEASEContact:        Oak Fund Services (Guernsey) LimitedCompany AdministratorAttn: Nicole BarnesTel: +44 1481 723450         Eurocastle Releases Fourth Quarter and Year End 2025 Financial Results Guernsey, 30 March 2026 – Eurocastle Investment Limited (Euronext Amsterdam: ECT) today has released its annual report for the year ended 31 December 2025.NAV of €20.60 million, or €20.51 per share, vs the Company’s previously reported Adjusted NAV of €15.01 per share as at Q3 2025 and €11.34 per share as at YE 2024, reflecting the release of all remaining Additional Reserves during 2025:During 2025, the Board determined that the reserves relating to the Realisation Plan were no longer required and these were released in full. This decision was taken in light...

Continue reading

2025 annual results: Equasens reports a solid performance across all financial indicators

Villers-lès-Nancy, 30 March 2026 – 08:00 (CEST) PRESS RELEASE          2025 annual resultsEquasens reports a solid performanceacross all financial indicatorsFY 2025 revenue of €236.5 million (+9.1%): continued strong performance driven by a portfolio of innovative solutions for healthcare professionals and providers Annual Recurring Revenue (ARR) up sharply: €108.0 million at December 31, 2025, representing 8.8% growth versus 2024EBITDA of €66.7 million (+9.1%), highlighting effective cost control in a sustained growth environmentCurrent operating income of €48.2 million (+6.8%), including the impact of investments in the new healthcare data infrastructureNet profit increased by 8.8% to €41.1 million, supporting the proposed distribution of a €1.40 gross dividend per share for FY 2025, subject to approval by the General...

Continue reading

DÉKUPLE GROUP – FULL-YEAR 2025 RESULTS: SOLID GROWTH AND IMPROVED SECOND-HALF PROFITABILITY

FULL-YEAR 2025 RESULTS: SOLID GROWTH AND IMPROVED SECOND-HALF PROFITABILITY_____Net sales: €242.6m (+ 11.4%) Net revenue (gross margin): €180.5m (+ 6.8%) EBITDA1: €23.7m (+0.8%), with a strong improvement in the second half (+38.4% vs. first half) Net income (Group share): €9.6m, representing 5.3% of net revenue Proposed dividend: €0.76 per share Ambition 2030: scaling the model and accelerating international expansionParis, 30 March 2026 (8h00) – ADLPartner, the parent company of the DÉKUPLE Group, a European leader in communication and data marketing, is reporting its full-year 2025 results. Bertrand Laurioz, DÉKUPLE Group Chairman and CEO: “2025 marks a new milestone in the transformation and international expansion of the DÉKUPLE Group. In a mixed economic environment, the Group continued its growth trajectory, with net sales reaching...

Continue reading

Enlight Research raises valuation and target share price for INVL Technology to EUR 5.05

Independent investment research firm Enlight Research has updated its valuation of INVL Technology, a company that invests in IT businesses which is seeking to divest its portfolio of investments, following the publication of preliminary results for 2025. Acknowledging the Group’s strong financial growth and significantly improved operational performance, Enlight Research increased the target share price for INVL Technology to EUR 5.05 (previously EUR 4.25). Under the optimistic scenario, the value reaches EUR 6.01 per share, while the conservative scenario estimates EUR 4.09. Before the release of the valuation report, INVL Technology’s share price on Nasdaq Vilnius stood at EUR 4.10. Enlight Research calculated that the weighted P/S (price-to-sales) multiple of the managed companies was 1.0x. In the fourth quarter of 2025, the companies...

Continue reading

Revised start time for the 2026 Annual General Meeting of HMS Networks AB (publ)

HMS Networks AB (publ) announces that the start time of the Annual General Meeting 2026 has been revised. The Annual General Meeting will be held on the previously communicated date and venue but will open at 11:00 a.m. CEST instead of 10:30 a.m. CEST. Registration for the meeting will take place from 9:30 a.m. CEST, in accordance with the notice of the Annual General Meeting.  In all other respects, the notice of the Annual General Meeting remains unchanged. For more information please contact: CEO Staffan Dahlström, phone: +46 (0)35-17 29 01 CFO Joakim Nideborn, phone: +46 (0)35-710 69 83 HMS Networks AB (publ) is a market-leading provider of solutions in Industrial Information and Communication Technology (Industrial ICT) and employs over 1,100 people. Local sales and support are handled through over 20 sales offices all over the world,...

Continue reading

Share repurchase programme: Transactions of week 13 2026Transaction in Own Shares

The share repurchase programme runs as from 5 February 2026 and up to and including 29 January 2027 at the latest. In this period, Jyske Bank will acquire shares with a value of up to DKK 3 billion, cf. Corporate Announcement No. 11/2026 of 5 February 2026. The share repurchase programme is initiated and structured in compliance with the Market Abuse Regulation (Regulation (EU) No 596/2014) and the Commission Delegated Regulation (EU) 2016/1052 of 8 March 2016 (together with the Market Abuse Regulation, the “Safe Harbour Rules”). The following transactions have been made under the program:  Number of shares Average purchase price (DKK) Transaction value (DKK)Accumulated, previous announcement 468,013 921.07 431,072,62723 March 2026 17,514 840.88 14,727,22524 March 2026 15,765 845.45 13,328,55725 March 2026 16,302 862.14 14,054,62726...

Continue reading

Virtualware Reports Audited 2025 Results: Margin Improvement and Record Bookings

Gross margin rises to 93.7%, EBITDA reaches €672K (15.53% margin), and the company moves to a pro forma net cash position Bilbao, March 30, 2026.- Virtualware (Euronext Growth Paris: ALVIR) closed 2025 with a gross margin of 93.7%, up from 86.8% in the prior year, and EBITDA of €672,626 (15.53% margin), according to audited annual results filed today with Euronext. The figures confirm the operational picture outlined in the February preliminary communication and show margin improvement, reflecting discipline and resilience throughout the year. Audited revenues reached €4.32 million, in line with the preliminary figure. The EBITDA improvement from the €598,500 (13.8%) reported in the unaudited release reflects the final allocation of depreciation and subsidy recognition under the audited close. The gross margin expansion was driven by the...

Continue reading

Outcome of Subscription to Coop Pank AS Unsecured Subordinated Bonds

The public offering of Coop Pank AS (hereinafter Coop Pank) unsecured subordinated bonds ended on Friday, 27 March. In the course of the Offering, up to 10,000 unsecured subordinated bonds of Coop Pank with the name of EUR 6,25 Coop Pank bond 26-2037, with the nominal value EUR 1,000 each, the maturity date 1 April 2037 and fixed interest rate of 6,25% per annum, payable quarterly, were offered. Under the terms of the Offering, in case of oversubscription, Coop Pank had the right to increase the volume of the Offering by up to 10,000 additional bonds. The Offering was only carried out in Estonia and not in any other jurisdiction. Altogether 3 853 investors participated in the issue, subscribing orders in the total amount of EUR 57,3 million. This means that the initial issue volume was oversubscribed 5,7 times. Coop Pank used its right...

Continue reading

Roche launches the cobas MPX-E assay, a new 4-in-1 donor screening test to further safeguard the global blood supply

The cobas MPX-E test provides four critical results (for HIV, HCV, HBV, and HEV) in a single test, increasing laboratory efficiency and decreasing healthcare costs. The new test delivers faster turnaround times and allows labs to implement Hepatitis E (HEV) screening without requiring additional instrumentation. This assay is designed for use on the fully automated cobas x800 systems, enabling high-throughput screening with up to 8 hours of walk-away time.Basel, 30 March 2026 – Roche (SIX: RO, ROP; OTCQX: RHHBY) announced today that the cobas® MPX-E assay, a qualitative in-vitro test for the detection and discrimination of Human Immunodeficiency Virus (HIV 1 and 2) and Hepatitis C, B, and E viruses, is now available in countries accepting the CE mark. This new assay represents a significant advancement in donor screening by consolidating...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.